Immunohistochemistry revealed positive staining for thyroglobulin, CK, HMWCK, CD99, and BCL-2, which led to the diagnosis of SETTLE. This evidence concerns the gene BCL2 and thyroid gland spindle cell tumor with thymus-like differentiation.